Certara
Certara's video was built to visually prove the clinical and regulatory ROI of their model-informed drug development software. The pharmaceutical industry faces extreme friction in rare disease research, where small patient pools and sensitive populations often stall crucial clinical trials. Without adopting virtual trials and predictive modeling, drug developers face prolonged development timelines, failed clinical trials, and regulatory rejection.
Our design team established a structured, clean-grid framework to anchor this clinical software overview presentation for Certara. We utilized a series of high-contrast data tables, crisp typography, and conceptual diagrams to systematically break down global regulatory thresholds and patient demographics. This typographic hierarchy simplifies dense regulatory criteria from the FDA and EMA, organizing complex criteria so that Biotech Executives immediately grasp the pathways to orphan drug designation.
To maintain high viewer engagement, we implemented subtle typographic transitions and clean slide-on graphics to guide the viewer through the therapeutic catalog. This rhythmic motion strategy transforms the B2B software capability profile from a static factsheet into an active, easy-to-follow narrative. By pairing generous whitespace with structured content sections, Advids managed to dramatically reduce cognitive fatigue and prevent viewer drop-off. Ultimately, the video's authoritative tone builds deep institutional trust, leading viewers naturally to the final call to action to read the white paper.